Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bc7c470585ebe2ae7e4d67546e5db41 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24F40-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24F40-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24F47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24F40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24F47-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24F40-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24F40-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24F47-00 |
filingDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ccf300f0945e5083571dc2c42aabecf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b4dc4ad929087e461abd01426a031b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b370034846ba9dce2e714c72cef80cf3 |
publicationDate |
2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019343169-A1 |
titleOfInvention |
Liquid formulation comprising nicotine for aerosol administration |
abstract |
In one aspect, the present invention features a method of administering nicotine or a salt thereof to a human, wherein the method includes inhaling an aerosol of a liquid formulation, the liquid formulation comprising: (i) at least 12 percent by weight of water; (ii) at least 70 percent by weight of propylene glycol; and (iii) at least 2 percent by weight of said nicotine or a salt thereof; wherein the liquid formulation includes no more than 5 percent by weight of glycerol and no more than 5 percent by weight of ethanol. The present invention also features an aerosol-generating device and a reservoir for such a device containing such a liquid formulation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021150856-A1 |
priorityDate |
2014-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |